The Journal of Korean Obstetrics and Gynecology (대한한방부인과학회지)

The Society of Korean Medicine Obstetrics and Gynecology (대한한방부인과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Partial Remission of End-stage Ovarian Cancer Patient with Lung Metastasis Treated with Carboplatin/Paclitaxel and Traditional Korean Medicine

Carboplatin/Paclitaxel과 한방치료를 병행하며 부분 관해 된 폐전이 동반 말기 난소암 1례

  • Received : 2021.10.13
  • Accepted : 2022.02.25
  • Published : 2022.02.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to report the effect of combination treatment of Traditional Korean medicine (TKM) and chemotherapy on a ovarian cancer with lung metastasis patient. Methods: One ovarian cancer with lung metastasis patient was treated by TKM in conjunction with Carboplatin/paclitaxel since Feb. 2020. Repeat cycle every 3 weeks for 6 times. The patient has been treated with TKM at the same time. To evaluate the patient, symptoms were measured by Numeric Rating Scale (NRS), Eastern Cooperative Oncology Group (ECOG) and tumor size was measured by scanning with Computed Tomography (CT). Blood tests including cancer biomarker were conducted during treatment. Adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), version 5.0. Results: After treatment with Carboplatin/paclitaxel and TKM during 2 months, the size of the ovarian cancer was decreased(Partial Response, PR), size and malignant pleural effusion at right lung disappeared. And no evidence of newly developed metastatic lesions. After 2 months, the tumor response was stable disease while improving the performance and other symptoms. Conclusions: This case provides us conjunctive treatment with Conventional and Eastern medicine may have substantial benefit for patients with end-stage ovarian cancer.

Keywords

References

  1. Korean Oncology textbook complication committee. Integrative Oncology of Korean Medicine. 2nd rev. ed. Paju: Gunja Publication. 2017:357-65.
  2. Kim KS, et al. Clinical Practice Guideline for Korean Medicine for Ovarian Cancer. J of Kor Traditional Oncology. 2016;21(2):37-50. https://doi.org/10.15432/JKTO.2016.21.2.037
  3. National Center Information Cancer. Annual report of cancer statistics in Korea in 2018[cited Jan 04, 2021]. Available from:URL:https://ncc.re.kr/cancerStatsList.ncc?sea.
  4. Park HM, et al. Gynecology. 5th rev ed. Korean Society of Obstetrics and Gynecology. Seoul:Korea Medical Book Publishing Co. 2018:809-53.
  5. National Center Information Cancer. Ovarian cancer, Side Effects of Treatment. Available from:URLhttps://www.cancer.go.kr/
  6. Yu SY, Nho JH. Influence of Sleep Disturbance and Depression on Quality of Life in Ovarian Cancer Patients during Chemotherapy. Asian Oncol Nurs. 2015;15(4):203-10. https://doi.org/10.5388/aon.2015.15.4.203
  7. Jin YJ, Shin KS, Ha JY. A Case of Improvement of Metastatic Ovarian and Endometrial Cancer Treated by Integrative Medicine Therapy Combined with Chemotherapy. J of Kor Traditional Oncology. 2014;19(1):33-41. https://doi.org/10.15432/JKTO.2014.19.1.33
  8. Han GJ, et al. A Case Study of a Patient with Breast Cancer Treated with a Combination of Traditional Korean Medicine and Chemotherapy. J Int Korean Med. 2017;38(5):820-7. https://doi.org/10.22246/jikm.2017.38.5.820
  9. Lee JH, Kim GH, Choi CM. A Case Report : Complications of Chemotherapy after Curative Resection in Patient with Ovarian CarcinomaIV. J Korean Obstet Gynecol. 2014;27(3):124-34. https://doi.org/10.15204/JKOBGY.2014.27.3.124
  10. Jung SH, et al. Clinical study on each case of secondary lymphedema in ovarian ca. and breast ca. which was cured by lymphmassage. J Korean Obstet Gynecol. 2001;14(2):250-63.
  11. Eisenhauer EA, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1). Eur J Cancer. 2009;45(2):228-47. https://doi.org/10.1016/j.ejca.2008.10.026
  12. Hawker GA, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care and Research. 2011;63(S11):240-52. https://doi.org/10.1002/acr.20345
  13. National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.5.0, 2017. Available from : URL: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/
  14. Cho JG. Oriental clinical oncology. 2nd rev. ed. Deajeon:Jumin Publication. 2005:135, 357-73.
  15. Kim JM. Integrated Cancer Treatment Roadmap. 1st rev ed. Goyang:Seohyun publishing. 2014:47.
  16. Korean Society of Gynecologic Oncology. Practice Guideline for Ovarian Cancer (ver. 4.0). [cited Aug, 2020]. Available from:URL:http://www.sgo.or.kr/
  17. Whang DY. New Bangyakhappyon. 2nd rev. ed. Seoul:Younglim publishing. 2010:139.
  18. Huh MG, et al. Experimental Study on the Anti-allergic Effects of Palmul-tang. Journal of physiology & pathology in Korean Medicine. 2003;7(4):1075-81.
  19. Kwon OB, Lim HH. Effects of Palmul-tang(Bawu-tang) and Kamipalmul-tang (Jiaweibawu-tang) on the Recovery of Fatigue in Rats. Journal of oriental rehabilitation medicine. 2002;12(1):89-100.
  20. Textbook Compilation Committee of National Universitiy of Korean Medicine. Herbology. Seoul:Yeonglimsa. 1991:439.
  21. Jang HJ. Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemoresistance in MCF-7/DOX cells. Graduate School of Korean Medicine, Kyunghee University. 2017:16.
  22. Kwon EM, et al. A Case of Metastatic Low-grade Endometrial Stromal Sarcoma Patient Managed with Allergen-removed Rhus Verniciflua Stokes Based on Traditional Korean Medicine. J of Kor Traditional Oncology. 2011;16(2):1-8. https://doi.org/10.15432/JKTO.2011.16.2.001
  23. Choi WC, et al. Study on Antiangiogenic and Antitumor Activities of Processed Rhus verniciflua Stokes extract. Journal of Physiology & Pathology in Korean Medicine. 2006;20(4):825-9.